person

Gema A.

Country
Spain
Department
Paediatric Nephrology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
81
Sites with multiple studies

Has run more than one trial at 81 of 135 partner sites.

Specializations

Pediatric Nephrology

The investigator specializes in treating various kidney conditions in children and adolescents, with particular focus on Autosomal Recessive Polycystic Kidney Disease (ARPKD) in infants and young patients. Their expertise extends to managing chronic kidney disease in pediatric populations from infancy through adolescence.

  • ARPKD Treatment Development
  • Pediatric Renal Disease Management
  • Chronic Kidney Disease in Children

The research encompasses therapeutic approaches for kidney conditions affecting patients from 28 days to 18 years of age.

Renal Complications

Primary focus areas include the treatment of proteinuria and associated kidney conditions. The investigator works with innovative therapeutic approaches for managing pruritus in patients with kidney disease and studies treatments for C3 Glomerulopathy.

  • Proteinuria Management
  • Uremic Pruritus Treatment
  • Glomerular Diseases

Their work addresses both primary kidney conditions and secondary complications of renal disease.

Rare Kidney Disorders

The investigator has developed expertise in treating rare kidney conditions, including Primary Hyperoxaluria and immune-complex membranoproliferative glomerulonephritis. Their work includes managing patients with severe renal impairment requiring dialysis.

  • Rare Disease Therapeutics
  • Complex Renal Disorders
  • Dialysis Management

Special attention is given to developing treatment strategies for patients with rare and complex kidney disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.